Summary:
Secondary hyperparathyroidism (sHPT) arises when the parathyroid glands overproduce PTH in response to chronic calcium deficiency, often due to kidney disease or vitamin D deficiency. This leads to weakened bones, muscle weakness, and potential calcifications. Treatment focuses on addressing the underlying cause, typically with medications to regulate calcium, phosphate, or vitamin D supplementation.

Details:
Secondary hyperparathyroidism is a compensatory response to chronic low blood calcium levels, unlike primary hyperparathyroidism, where excess PTH is autonomous.

Causes:

• Chronic Kidney Disease (CKD): Reduced vitamin D activation and phosphate excretion lead to calcium deficiency.
• Vitamin D Deficiency: Decreased calcium absorption in the intestine.
• Malabsorption: Gastrointestinal conditions impairing calcium absorption.

Symptoms:

• Bone Pain and Weakness: From increased bone resorption.
• Muscle Weakness.
• Fatigue and General Weakness.
• Joint Pain.
• Calcifications: In soft tissues and vessels.

Diagnosis:

• Elevated PTH with low or normal blood calcium levels.
• Often increased phosphate and decreased vitamin D levels, particularly in CKD patients.

Treatment:

• CKD Management: Phosphate binders, active vitamin D, and dietary adjustments.
• Vitamin D Deficiency: Vitamin D supplements and calcium if needed.
• Surgery: For severe cases unresponsive to conservative measures.